Treatment of Myocardial Infarction With Bone Marrow Derived Stem Cells
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00275977|
Recruitment Status : Unknown
Verified January 2006 by Odense University Hospital.
Recruitment status was: Recruiting
First Posted : January 12, 2006
Last Update Posted : July 23, 2010
|Condition or disease||Intervention/treatment||Phase|
|Acute Myocardial Infarction||Procedure: Coronary catherization and stem cell infusion||Phase 1|
Primary coronary intervention within a few hours of a myocardial infarction has greatly reduced mortality as well as the risk of developing chronic heart failure. There are though still a large number of patients that develop symptoms of heart failure in the form of fatigue and breathlessness with physical exertion in spite of medical treatment. With the advance in stem cell technology there is now hope for the possibility of regenerating/repairing dead myocardial tissue, hence improving cardiac function.
The current study is a pilot study that is going to precede a later double blinded randomized study. The aim of the study is to evaluate patient safety, optimize procedures, and to be used in power calculation in the design of the following study.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Treatment of Myocardial Infarction With Autologous Bone Marrow Derived Stem Cells|
|Study Start Date :||February 2006|
|Study Completion Date :||March 2007|
- Change in left ventricular funtion at 4 months followup using contrast enhanced echocardiography
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00275977
|Contact: Malthe AM Kristiansen, MD||+45 firstname.lastname@example.org|
|Department of endocrinology M, Odense University Hospital||Recruiting|
|Odense, Denmark, 5000|
|Sub-Investigator: Malthe AM Kristiansen, MD|
|Principal Investigator: Moustapha Kassem, MD, Ph.D|
|Principal Investigator:||Moustapha Kassem, MD, Ph.D||Department of endocrinology M, Odense University Hospital|